Drug Shortage Report for CERETEC
Report ID | 238131 |
Drug Identification Number | 02329034 |
Brand name | CERETEC |
Common or Proper name | Kit for the Preparation of Technetium-99m Exametazime Injection |
Company Name | GE HEALTHCARE CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | EXAMETAZIME |
Strength(s) | 0.5MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5 vial kit |
ATC code | V09HA |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-09-23 |
Actual start date | |
Estimated end date | 2024-09-27 |
Actual end date | 2024-09-24 |
Shortage status | Resolved |
Updated date | 2024-09-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-09-25 | French | Compare |
v4 | 2024-09-25 | English | Compare |
v3 | 2024-09-24 | English | Compare |
v2 | 2024-09-20 | French | Compare |
v1 | 2024-09-20 | English | Compare |
Showing 1 to 5 of 5